Comparison Chart Colinz Laboratories Limited

COLINZ6

INE923C01011

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	COLINZ LABORATORIES LIMITED	Generic Pharmaceuticals	+3.45%	+2.74%	+39.85%	+80.29%	+296.83%	1.91M	-	-	-

07-30	Colinz Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06-17	Annjana Dugar, Likhitta Dugar and Antariksh Dugar executed of Share Purchase Agreement to acquire an additional 34.56% stake in Colinz Laboratories Limited from Vijaya Mani for INR 43.5 million,	CI

Delayed Bombay S.E. 04:44:44 2026-09-15 EDT			5-day change	1st Jan Change
75.00 ^INR	+3.45%		+2.74%	+39.85%

Comparison Chart Colinz Laboratories Limited

Stocks

COLINZ6

INE923C01011

Pharmaceuticals

Compared values